PathomIQ Inc., headquartered in Silicon Valley ,USA, was founded by a team of outstanding biomarker discovery researchers, data scientists and clinicians with extensive experience in their areas of specialty.
Core Team
Rajat Roy
CEO
Serial Entrepreneurial Executive
George Wilding, MD
CMO
Former Vice Provost of Multidisciplinary Clinical Research, MD Anderson Cancer Center
Parag Jain
VP Products & Data Science
Former Product Management and Big Data Executive, Stanford University MS
Wei Huang, MD
Chief Pathologist
Professor & Clinical Pathologist, UW
Post Doctoral Fellow, Harvard / Brigham Women Hospital
Hassan Muhammad, PhD
Principal AI Scientist
Former Computational Pathology Researcher at MSKCC, Cornell University PhD
Chensu Xie, PhD
Principal AI Scientist
Former Computational Pathology Researcher at MSKCC, Cornell University PhD
Scientific Advisory Board
George Wilding, MD
Chief Medical Officer
Former Vice Provost of Multidisciplinary Clinical Research, MD Anderson Cancer Center
Hirak Basu, PhD
Assoc Professor, MD Anderson Cancer Center
Former Sr. Scientist UCSF
Shivaani Kummar, MD
DeArmond Endowed Chair of Cancer Research and co-Director, Center of Experimental Therapeutics, OHSU/KCI
Former Professor of Medicine, Medical Oncologist, Stanford Medical, Yale and NCI
Ramandeep Randhawa, PhD
Vice Dean for Undergraduate Programs and Professor of Data Sciences and Operations at USC Marshall School of Business
Stanford University, PhD
Debashish Roychowdhury, MD
CMO, Partner Therapeutics
Former Sr VP, Head of Global Oncology Drug Development Sanofi, GSK, Eli Lilly
Janak Desai, MS, MCh, FRCS
Chief Urologist, Samved Hospital
Honorary member of German, UK & Japan Urological Society